Skip to main content

Military Health System

COVID-19 Booster Effectiveness Remained High During Omicron Surge

Image of Hospital Corpsman 1st Class Mary Ashcraft, assigned to the combat ship USS Tulsa, administers a COVID-19 vaccine booster to Aviation Machinist Mate 1st Class Anthony Johnson Jan. 10, 2022, at Apra Harbor, Guam. (Photo: Mass Communication Specialist Petty Officer 1st Class Devin M. Langer, Command Destroyer Squadron 7). Hospital Corpsman 1st Class Mary Ashcraft, assigned to the combat ship USS Tulsa, administers a COVID-19 vaccine booster to Aviation Machinist Mate 1st Class Anthony Johnson Jan. 10, 2022, at Apra Harbor, Guam. (Photo: Mass Communication Specialist Petty Officer 1st Class Devin M. Langer, Command Destroyer Squadron 7)

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

Active-duty service members who received a COVID-19 vaccine booster shot were significantly less likely to be infected and show symptoms of the disease during the surge of the Omicron variant this winter, according to a recent study. 

The study highlights the effectiveness of booster shots, which were first formally recommended by the Centers for Disease Control and Prevention in November. 

“The findings support the policy of booster doses at five months after the primary series and show improved vaccine effectiveness with a booster dose even during times of a newly emerging SARS-CoV-2 variant,” said Shauna Stahlman. She is a senior epidemiologist in the Epidemiology and Analysis Branch of the Armed Forces Health Surveillance Division

But a separate study also found that the number of active-duty service members who were voluntarily getting booster shots lagged behind the general U.S. population. 

As of Jan. 31, only 24% of active-duty service members who were eligible for a booster had voluntarily received the additional shot, according to Army Col. (Dr.) James Mancuso. Mancuso chairs the Preventive Medicine and Biostatistics Department at the Uniformed Services University of Health Sciences’ Hebert School of Medicine. His group led the booster uptake study in collaboration with Stahlman and AFHSD. 

By comparison, in the general U.S. population as of Feb. 10, about 46.8% of the booster-eligible population had received the additional shot. “This is likely reflective of [active-duty service members] being a relatively younger and healthier population,” Stahlman said. 

The study found that service members were less likely to get a booster shot if they were younger, lower in rank or had lower education levels. Similar studies of the civilian population show that younger and healthier people have been less likely to seek out vaccines and booster shots. 

Overall, the rate at which service members sought out and received booster shots increased during the surge of infections linked to the Omicron variant beginning in December 2021. Vaccine uptake among active-duty service members also went up in November 2021 after the CDC recommended that all adults get a booster, Stahlman noted. 

The Pentagon mandated initial COVID-19 vaccinations for service members in August 2021. However, booster shots remain voluntary. 

Booster Mandate Coming? 

Stahlman said the study’s findings suggest that “high levels of booster uptake among [active-duty service members] are unlikely to be accomplished on a voluntary basis.” 

In mid-December, the Pentagon said there were “active discussions” within the DOD about making the booster shots mandatory for service members. The Defense Department has not issued any requirement for a booster because the booster doses are only used under emergency authorization. The primary vaccination series (e.g., generally the first two shots) are fully approved by the Food and Drug Administration. 

Mancuso said that currently, the best way to promote booster vaccination is to encourage service members to discuss their own personal risks of COVID-19 and benefits from getting the booster shot with their primary unit-level health care providers.  

“These providers should be encouraging vaccination due to its benefits to the health of the individual as well as to military readiness and overall the health of the force.” 

FDA’s vaccine advisory committee met April 6 on questions about booster doses. The CDC has not yet scheduled a meeting on the subject of boosters with its advisory group on vaccines. 

Who Didn’t Get Boosted 

The study found that active-duty service members were less likely to get a booster shot if they had a previous COVID-19 infection. Active-duty service members in the U.S. received fewer boosters compared to those stationed overseas. 

Other factors that appeared to result in lower booster uptake were being male and serving in the Marine Corps. 

The study did not find any significant differences in booster shot uptake among different races and ethnicities, as was seen in a previous study of the primary vaccination series. 

Booster Vaccine Effectiveness 

Vaccine effectiveness “was significantly higher” among service members who received a booster shot compared to those who only received the initial vaccination, regardless of the month or time since their primary vaccination, Stahlman said. 

Even during the surge, service members who received a booster shot had 43% to 63% reduced odds of developing symptomatic COVID-19 when compared to those who were vaccinated with the primary series but didn’t receive the booster, according to the study. 

“Our patterns of vaccine effectiveness estimates are generally similar to those observed in the U.S. population and among military veterans,” she added. 

The booster vaccine effectiveness study reviewed military vaccination data for active-duty service members who were tested for SARS-CoV-2 between July 2021 and January 2022. The study evaluated the three existing vaccines from Pfizer/BioNTech, Moderna, and Johnson & Johnson/Janssen. 

You also may be interested in...

COVID-19 Moderna and Pfizer Vaccines

Publication
8/17/2022

Moderna and Pfizer mRNA vaccines are available. Moderna includes two doses, 28 days apart. Pfizer includes two doses, 21 days apart. Remember to mark your calendar and schedule time for your second dose

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Moderna Vaccine

Publication
8/17/2022

Moderna and mRNA vaccines are available. Moderna includes two doses, 28 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Pfizer Vaccine

Publication
8/17/2022

Pfizer mRNA vaccines are available. Pfizer includes two doses, 21 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

Formulary Search Tool Buckslip: Color

Publication
1/27/2022

A color copy of buck slips on the TRICARE Formulary Search Tool. Educates beneficiaries what the search tool is and what information can be found. Includes a QR code, and features a link to esrx.com/tform. ESI and TRICARE logos are on the bottom right.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Pharmacy Operations Toolkit

Formulary Search Tool Buckslip: Black and White

Publication
1/27/2022

A set of three, black & white buck slips on the TRICARE Formulary Search Tool. Educates beneficiaries what the search tool is and what information can be found. Includes a QR code, and features a link to esrx.com/tform. ESI and TRICARE logos are on the bottom right.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Pharmacy Operations Toolkit

Get to know the COVID19 Vaccines

Publication
9/17/2021

Get to know the vaccines – they do not contain the live virus, they do not interact with our DNA, and have been tested rigorously.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

Get to Know the Vaccines

Publication
9/17/2021

A graphic showing the types of vaccines, how they work, and safety monitoring of the vaccines. Includes the MHS and TRICARE logos on the bottom right, and includes graphics of scientists, doctors, and patients.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

Line Leader Presentation (PDF)

Publication
8/4/2021

This document is identical to the PowerPoint presentation for line leader reference and use.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

Line Leader Presentation (Powerpoint)

Publication
8/4/2021

Leaders across the Department can leverage this briefing deck to discuss COVID-19 vaccines with their troops. Don't forget to reference speaker notes and to personalize the title slide!

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

VAX Facts about Getting the COVID Vaccine at the Same Time as Others

Publication
6/9/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts

COVID-19 Vaccine Safety Monitoring

Publication
6/9/2021

The FDA and CDC continue to monitor the safety of COVID-19 vaccines. CDC has an independent group of experts that reviews all the safety data as it comes in and provides regular safety updates.

Recommended Content:

Get to Know the COVID-19 Vaccines | Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts

How COVID-19 Vaccines Work

Publication
6/9/2021

Learn how the different COVID-19 vaccines work.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts

Get to Know the COVID-19 Vaccines

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts

Get to Know the COVID-19 Vaccines (Combined)

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19. Learn about the vaccines, how they work and safety precautions.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts

COVID-19 Vaccine Leader Card

Publication
5/27/2021

This printable card provides talking points when discussing the COVID-19 vaccine with servicemembers who are reluctant or indifferent to accepting the vaccine. The card lists common concerns and impressions, top 5 key messages, and supporting facts about the vaccine.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts
<< < 1 2 3 4 5 > >> 
Showing results 1 - 15 Page 1 of 5
Refine your search
Last Updated: February 01, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery